Shearman & Sterling advised Goldman Sachs International as global co-ordinator, Barclays, HSBC, Morgan Stanley as arrangers and physical bookrunners and BNP Paribas, Deutsche Bank’s London Branch, J.P. Morgan, Natixis and Unicredit Bank as book-runners in connection with a €920 million term loan B financing maturing in July 2026. The proceeds of the term loan will be used to repay SYNLAB’s existing €900 million of senior secured notes maturing in 2022.
SYNLAB is the pre-eminent clinical laboratory services company in Europe. It operates across 35 countries on three continents and undertakes more than 500 million clinical tests for more than 50 million patients annually.
The Shearman & Sterling team below included associate Anna Shelton.